Edinburgh Research Explorer Phylogenetic surveillance of viral genetic diversity and the evolving molecular epidemiology of human immunodeficiency virus type 1
暂无分享,去创建一个
Anne-Mieke Vandamme | Paul Kellam | David Dunn | Andrew Rambaut | Tulio de Oliveira | Robert J. Gifford | Oliver G. Pybus | Deenan Pillay | O. Pybus | D. Pillay | A. Rambaut | A. Vandamme | P. Kellam | K. Deforche | T. de Oliveira | R. Gifford | D. Dunn | P. Lemey | Robert J. Gifford | Tulio de Oliveira | David Dunn | Deenan Pillay | David Dunn | Paul Kellam | Y. Moreau | Robert J Gifford | R. Camacho | K. V. Laethem | A. Rambaut
[1] D. Richman,et al. 2022 update of the drug resistance mutations in HIV-1. , 2022, Topics in antiviral medicine.
[2] E. Sanders-Buell,et al. Identification of CRF34_01B, a second circulating recombinant form unrelated to and more complex than CRF15_01B, among injecting drug users in northern Thailand. , 2007, AIDS research and human retroviruses.
[3] Anne-Mieke Vandamme,et al. Recombination Confounds the Early Evolutionary History of Human Immunodeficiency Virus Type 1: Subtype G Is a Circulating Recombinant Form , 2007, Journal of Virology.
[4] Soo-Yon Rhee,et al. HIV-1 protease and reverse transcriptase mutations for drug resistance surveillance , 2007, AIDS.
[5] Yves Moreau,et al. Analysis of HIV-1 pol sequences using Bayesian Networks: implications for drug resistance , 2006, Bioinform..
[6] Y. Takebe,et al. Identification of a Novel Circulating Recombinant Form (CRF33_01B) Disseminating Widely Among Various Risk Populations in Kuala Lumpur, Malaysia , 2006, Journal of acquired immune deficiency syndromes.
[7] Tulio de Oliveira,et al. Molecular Epidemiology: HIV-1 and HCV sequences from Libyan outbreak , 2006, Nature.
[8] P. Ghys,et al. Global and regional distribution of HIV-1 genetic subtypes and recombinants in 2004 , 2006, AIDS.
[9] Deenan Pillay,et al. Update of the drug resistance mutations in HIV-1: Fall 2006. , 2006, Topics in HIV medicine : a publication of the International AIDS Society, USA.
[10] Anne-Mieke Vandamme,et al. Assessment of automated genotyping protocols as tools for surveillance of HIV-1 genetic diversity , 2006, AIDS.
[11] Nicholas Eriksson,et al. Evolution on distributive lattices. , 2005, Journal of theoretical biology.
[12] A. Vandamme,et al. Interpreting resistance data for HIV-1 therapy management--know the limitations. , 2006, AIDS reviews.
[13] N. Wolfe,et al. HIV type 1 CRF13_cpx revisited: identification of a new sequence from Cameroon and signal for subsubtype J2. , 2005, AIDS research and human retroviruses.
[14] M. Peeters,et al. Distribution of HIV-1 Variants in the Democratic Republic of Congo Suggests Increase of Subtype C in Kinshasa Between 1997 and 2002 , 2005, Journal of acquired immune deficiency syndromes.
[15] Thomas Lengauer,et al. Data and text mining Computational methods for the design of effective therapies against drug resistant HIV strains , 2005 .
[16] M. Thomson,et al. Molecular epidemiology of HIV-1 variants in the global AIDS pandemic: an update. , 2005, AIDS reviews.
[17] Tulio de Oliveira,et al. An automated genotyping system for analysis of HIV-1 and other microbial sequences , 2005, Bioinform..
[18] D. Posada,et al. Identification of a novel HIV-1 complex circulating recombinant form (CRF18_cpx) of Central African origin in Cuba , 2005, AIDS.
[19] D. Bennett. HIV-1 Genetic Diversity Surveillance in the United States , 2005 .
[20] J. Bartkus,et al. HIV-1 subtype diversity in Minnesota. , 2005, The Journal of infectious diseases.
[21] J. Carr,et al. HIV type 1 strains common in Europe, Africa, and Asia cocirculate in Yemen. , 2005, AIDS research and human retroviruses.
[22] Thomas Lengauer,et al. Estimating HIV evolutionary pathways and the genetic barrier to drug resistance. , 2005, The Journal of infectious diseases.
[23] Stéphane Hué,et al. Genetic analysis reveals the complex structure of HIV-1 transmission within defined risk groups. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[24] S. Dougan,et al. HIV infections acquired through heterosexual intercourse in the United Kingdom: findings from national surveillance , 2005, BMJ : British Medical Journal.
[25] D. Pillay,et al. Investigation of HIV-1 transmission events by phylogenetic methods: requirement for scientific rigour. , 2005, AIDS.
[26] Thomas Lengauer,et al. Learning multiple evolutionary pathways from cross-sectional data , 2004, J. Comput. Biol..
[27] D. Bennett. HIV [corrected] genetic diversity surveillance in the United States. , 2005, The Journal of infectious diseases.
[28] J. Takehisa,et al. Genetic Diversity of HIV Type 1 in Rural Eastern Cameroon , 2004, Journal of acquired immune deficiency syndromes.
[29] F. McCutchan,et al. Distinct Human Immunodeficiency Virus Type 1 Subtype A Virus Circulating in West Africa: Sub-Subtype A3 , 2004, Journal of Virology.
[30] Rafael Sanjuán,et al. The contribution of epistasis to the architecture of fitness in an RNA virus. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[31] Michael P. Cummings,et al. PAUP* [Phylogenetic Analysis Using Parsimony (and Other Methods)] , 2004 .
[32] J. Carr,et al. Drug resistance testing provides evidence of the globalization of HIV type 1: a new circulating recombinant form. , 2004, AIDS research and human retroviruses.
[33] JD Lundgren,et al. Updated European Recommendations for the Clinical Use of HIV Drug Resistance Testing , 2004, Antiviral therapy.
[34] Stéphane Hué,et al. HIV-1 pol gene variation is sufficient for reconstruction of transmissions in the era of antiretroviral therapy , 2004, AIDS.
[35] K. Crandall,et al. The causes and consequences of HIV evolution , 2004, Nature Reviews Genetics.
[36] M. Peeters,et al. Genetic diversity of HIV in Africa: impact on diagnosis, treatment, vaccine development and trials , 2003, AIDS.
[37] Susan Zolla-Pazner,et al. Genetic and biological properties of HIV type 1 isolates prevalent in villagers of the Cameroon equatorial rain forests and grass fields: further evidence of broad HIV type 1 genetic diversity. , 2003, AIDS research and human retroviruses.
[38] Yutaka Takebe,et al. High prevalence of diverse forms of HIV-1 intersubtype recombinants in Central Myanmar: geographical hot spot of extensive recombination , 2003, AIDS.
[39] M. Peeters,et al. High genetic diversity of HIV-1 strains in Chad, West Central Africa. , 2003, Journal of acquired immune deficiency syndromes.
[40] R. Parreira,et al. Spreading of HIV-1 subtype G and envB/gagG recombinant strains among injecting drug users in Lisbon, Portugal. , 2003, AIDS research and human retroviruses.
[41] Ester C Sabino,et al. A specific subtype C of human immunodeficiency virus type 1 circulates in Brazil , 2003, AIDS.
[42] D. Maddison,et al. MacClade 4: analysis of phy-logeny and character evolution , 2003 .
[43] S. Yerly,et al. Travel and the spread of HIV-1 genetic variants. , 2003, The Lancet. Infectious diseases.
[44] Henry Tirri,et al. B-Course: A Web-Based Tool for Bayesian and Causal Data Analysis , 2002, Int. J. Artif. Intell. Tools.
[45] Y. Takebe,et al. On-going generation of multiple forms of HIV-1 intersubtype recombinants in the Yunnan Province of China , 2002, AIDS.
[46] Alexei J Drummond,et al. Estimating mutation parameters, population history and genealogy simultaneously from temporally spaced sequence data. , 2002, Genetics.
[47] Jaap Goudsmit,et al. Recent Evolutionary History of Human Immunodeficiency Virus Type 1 Subtype B: Reconstruction of Epidemic Onset Based on Sequence Distances to the Common Ancestor , 2002, Journal of Molecular Evolution.
[48] Robert W. Shafer,et al. Genotypic Testing for Human Immunodeficiency Virus Type 1 Drug Resistance , 2002, Clinical Microbiology Reviews.
[49] R. Parreira,et al. Molecular epidemiology of HIV type 1 infection in Portugal: high prevalence of non-B subtypes. , 2002, AIDS research and human retroviruses.
[50] A. Vandamme,et al. A Genotypic Drug Resistance Interpretation Algorithm that Significantly Predicts Therapy Response in HIV-1-Infected Patients , 2001, Antiviral therapy.
[51] D. Ho,et al. Evidence of two distinct subsubtypes within the HIV-1 subtype A radiation. , 2001, AIDS research and human retroviruses.
[52] J. Fantini,et al. Use of drug resistance sequence data for the systematic detection of non-B human immunodeficiency virus type 1 (HIV-1) subtypes: how to create a sentinel site for monitoring the genetic diversity of HIV-1 at a country scale. , 2001, The Journal of infectious diseases.
[53] G. Van der Auwera,et al. Reanalysis of full-length HIV type 1 group M subtype K and sub-subtype F2 with an MS-DOS bootscanning program. , 2001, AIDS research and human retroviruses.
[54] Matthew J. Gonzales,et al. Human Immunodeficiency Virus Reverse Transcriptase and Protease Sequence Database: an expanded data model integrating natural language text and sequence analysis programs , 2001, Nucleic Acids Res..
[55] Allen G. Rodrigo,et al. Testing the Hypothesis of a Recombinant Origin of Human Immunodeficiency Virus Type 1 Subtype E , 2000, Journal of Virology.
[56] Martine Peeters,et al. Unprecedented Degree of Human Immunodeficiency Virus Type 1 (HIV-1) Group M Genetic Diversity in the Democratic Republic of Congo Suggests that the HIV-1 Pandemic Originated in Central Africa , 2000, Journal of Virology.
[57] M. P. Cummings,et al. PAUP* Phylogenetic analysis using parsimony (*and other methods) Version 4 , 2000 .
[58] J. Coffin,et al. Linkage disequilibrium test implies a large effective population number for HIV in vivo. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[59] David L. Robertson,et al. An Isolate of Human Immunodeficiency Virus Type 1 Originally Classified as Subtype I Represents a Complex Mosaic Comprising Three Different Group M Subtypes (A, G, and I) , 1998, Journal of Virology.
[60] T. Leitner,et al. Stochastic processes strongly influence HIV-1 evolution during suboptimal protease-inhibitor therapy. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[61] M. Salminen,et al. HIV‐1 genetic subtype A/B recombinant strain causing an explosive epidemic in injecting drug users in Kaliningrad , 1998, AIDS.
[62] M. Peeters,et al. Presence of multiple non‐B subtypes and divergent subtype B strains of HIV‐1 in individuals infected after overseas deployment , 1997, AIDS.
[63] D J Hu,et al. The emerging genetic diversity of HIV. The importance of global surveillance for diagnostics, research, and prevention. , 1996, JAMA.
[64] L. M. Mansky,et al. Lower in vivo mutation rate of human immunodeficiency virus type 1 than that predicted from the fidelity of purified reverse transcriptase , 1995, Journal of virology.
[65] D. Brutlag,et al. Discovering structural correlations in α‐helices , 1994 .
[66] M Slatkin,et al. A cladistic measure of gene flow inferred from the phylogenies of alleles. , 1989, Genetics.
[67] L B Sheiner,et al. Kinetics of pharmacologic response. , 1982, Pharmacology & therapeutics.
[68] W. Ewens. Mathematical Population Genetics , 1980 .